Clebopride
![]() | |
![]() | |
Systematic (IUPAC) name | |
---|---|
4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro- 2-methoxybenzamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number |
55905-53-8 ![]() |
ATC code | A03FA06 (WHO) |
PubChem | CID 2780 |
ChemSpider |
2678 ![]() |
UNII |
I0A84520Y9 ![]() |
KEGG |
D03534 ![]() |
ChEMBL |
CHEMBL325109 ![]() |
Chemical data | |
Formula | C20H24ClN3O2 |
Molar mass | 373.876 g/mol |
| |
| |
(verify) |
Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide.
A small Spanish study found that more adverse reactions are reported with clebopride than with metoclopramide, particularly extrapyramidal symptoms.[1]
References
- ↑ Cuena Boy R, Maciá MartÃnez MA (1998). "[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System]". Atencion Primaria (in Spanish) 21 (5): 289–95. PMID 9608114. Free full text
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.